Affinity of myasthenia drugs to acetylcholinesterase and acetylcholine receptor.
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D002462:Cell Membrane / Q000378:metabolism; D002800:Cholinesterase Inhibitors; D003600:Cytosol / Q000378:metabolism; D004491:Edrophonium / Q000378:metabolism* / Q000494:pharmacology; D004557:Electric Organ / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D005399:Fishes; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009157:Myasthenia Gravis; D009388:Neostigmine / Q000378:metabolism* / Q000494:pharmacology; D011485:Protein Binding; D011729:Pyridostigmine Bromide / Q000378:metabolism* / Q000494:pharmacology; D011950:Receptors, Cholinergic; D014316:Tritium
D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D014316:Tritium; D009388:Neostigmine; D004491:Edrophonium; D000110:Acetylcholinesterase; D011729:Pyridostigmine Bromide